January 13, 2025January 15, 2025 Ronsard Mondesir Why Prospect Filed for Chapter 11 and What It Means for the Astrana Health Deal
January 6, 2025January 14, 2025 Ronsard Mondesir Historical M&A Deals and Tax Minimization Strategies: Lessons from the Pfizer-Allergan Case
January 3, 2025January 14, 2025 Ronsard Mondesir 8 Key Insights from “Goldman Sachs’ 2025 M&A Outlook”